Although the involvement of SHMT1 in hepatic immune regulation remains unconfirmed, it is possible that SHMT1 deficiency or dysfunction may influence MASLD-related inflammatory responses through the NF-κB pathway, thereby contributing to disease progression from steatosis to liver fibrosis or even HCC. Here, SHMT1 is linked to hepatocellular carcinoma.